2017 ASH Meeting on Hematologic Malignancies
Programme du congrès
The ASH Meeting on Hematologic Malignancies features the top experts
in the field, comprehensive clinical content, and the opportunity to
interact with colleagues in an intimate, small-group setting with no
competing sessions. Attend the 2018 meeting to hear experts present
cutting-edge scientific data, provide out-of-the-box treatment
approaches, answer challenging patient care questions during topic-based
panel discussions, and engage in stimulating conversations on specific
disease topics during “Lunch With the Experts” sessions.The
program content is structured as "How I Treat" presentations, which
showcase each speaker's evidence-based treatment approaches. Learn how
new data can be translated into new strategies for diagnosis and
treatment, find out what to do in cases where there is no data, and gain
knowledge that can help you make an immediate impact on your practice. Hear exciting updates in each of the core hematologic malignancies, including:
- Leukemia
- Lymphoma
- Myelodysplastic syndromes
- Myeloma
- Myeloproliferative neoplasms
Jonathan Friedberg, MD, Co-Chair, 2017 ASH Meeting on Hematologic Malignancies
- Date : 08/09/2017
- 1 0
2017 ASH MHM: Focus on Lymphoma - John Leonard, MD, and Jonathan Friedberg, MD
- Date : 08/09/2017
- 0 0